No Data
No Data
H.C. Wainwright Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $18
H.C. Wainwright analyst Joseph Pantginis maintains $Tenaya Therapeutics(TNYA.US)$ with a buy rating, and maintains the target price at $18.According to TipRanks data, the analyst has a success rate
Optimistic Buy Rating for Tenaya Therapeutics Ahead of TN-201 Clinical Trial Data
Express News | Tenaya Therapeutics Announces Research Leadership Updates
Institutional Owners May Take Dramatic Actions as Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) Recent 17% Drop Adds to One-year Losses
Key Insights Significantly high institutional ownership implies Tenaya Therapeutics' stock price is sensitive to their trading actions 52% of the business is held by the top 9 shareholders Analys
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative
Express News | Tenaya Therapeutics Inc : William Blair Initiates Coverage With Outperform Rating